Full-Time

Director of Nursing

New York, New Jersey, Delaware, Remote

Posted on 11/1/2025

Option Care Health

Option Care Health

1,001-5,000 employees

Largest independent home infusion therapy provider

Compensation Overview

$143.8k - $239.6k/yr

+ Pay Range

Harrisburg, PA, USA + 8 more

More locations: Morristown, NJ, USA | Raleigh, NC, USA | Tallahassee, FL, USA | Brooklyn, NY, USA | Columbia, SC, USA | Atlanta, GA, USA | Dover, DE, USA | Montgomery, AL, USA

Hybrid

Category
People & HR (3)
, ,
Requirements
  • Registered Nurse with a license in the current state of practice.
  • At least 6 years of home health/infusion care experience.
  • Minimum of 3 years in a nursing leadership role within a home care setting.
Responsibilities
  • Directs the activities of the nursing department(s) for assigned location(s). Oversight of work schedules and activities of nursing staff so that the patient care needs are met, productivity standards are maintained, and overtime is controlled.
  • Works with the Area Director of Nursing to implement and operationalize the centralized scheduling model in the area following the outlined process for centralized nurse scheduling and administrative responsibilities for their location(s).
  • Complies with requirements of the Company and ensures that services are provided in a manner consistent with established standards of practice, federal and state regulations, accreditation standards and agency policy.
  • Ensures compliance with policies and procedures by the department and oversees the selection, development, and monitoring of nursing staff in assigned location(s).
  • Partners with the Nurse Manager and/or Nursing Supervisor on the supervision and evaluation of all nursing personnel who provide direct patient care and directs all human resource issues related to nursing and allied health services personnel, including recruitment, performance evaluations, disciplines, and terminations.
  • Partners with each location to ensure that all nurses providing care maintain professional standards of nursing practice. Support and drive supply formulary compliance by ensuring that nurses are monitoring patient supplies and maintaining adequate levels.
  • Assists Operations Leadership in preparing, securing approval for, and implementing operating and expenditure budgets for department, and operates within those guidelines.
  • Responsible for the coordination of patient services with the pharmacy, delivery, reimbursement, and other departments both internally and externally.
  • Establishes and ensures the purchase and expedition of medical supplies and equipment within budget constraints.
  • Participates in the process for assessing, managing, and reporting nursing operational and financial data to Operations Leaders, including analysis for trends and development of process improvement plans.
  • Ensures each location has a process to collect and organize all patient-specific information needed to determine the suitability of patients for home care.
  • Assesses patients’ suitability for home care in accordance with Option Care Health policies.
  • Verifies that the patient’s medical condition and prescribed therapy is suitable for home care.
  • Provides continuing education to physicians, nurses, pharmacy technicians, and other practitioners on home care infusion-related issues, including competency and orientation programs.
  • Ensures each location has a process for on-call responsibilities for the nursing department.
  • Facilitates a clinical networking system for the agency and acts as a clinical resource.
  • Meets all standards as outlined in all Nursing Leadership job descriptions.
Desired Qualifications
  • BSN with CRNI or other professional certification and Documentation of advanced management training.
  • At least 4 years of experience in a home health/infusion setting.

Option Care Health delivers infusion therapies at home and other alternate-site locations across the United States, supported by over 7,000 teammates including about 4,500 clinicians. Clinicians visit patients at home or approved sites to administer therapies, manage care, and coordinate with care teams under strong clinical leadership and national scale. It stands out as the largest independent infusion provider with nationwide reach and a robust clinical workforce, enabling scalable home and alternate-site infusion rather than hospital-only care. The goal is to elevate standards of care and reimagine the infusion care experience by expanding access, improving outcomes, and delivering compassionate, clinically driven service.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Norfolk, Virginia

Founded

1979

Simplify Jobs

Simplify's Take

What believers are saying

  • Expanded revolving credit facility to $850 million enables M&A flexibility.
  • Increased share repurchase authorization to $1 billion signals management confidence.
  • Operating cash flow exceeds $340 million in 2026, growing over 30%.

What critics are saying

  • Chronic Inflammatory Disease portfolio reset causes $55 million revenue headwind through 2026.
  • Stelara biosimilars and Inflation Reduction Act cut gross profit by $25-35 million.
  • EEOC pregnancy discrimination lawsuit triggers fines and talent exodus by 2027.

What makes Option Care Health unique

  • Largest national independent provider of home and alternate site infusion services.
  • Serves over 315,000 unique patients with high-quality infusion therapy options.
  • Selected by Quince Therapeutics for specialty infusion of lead asset eDSP.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Time Off

Bonding Time Off

401(k) Retirement Plan

401(k) Company Match

Health Savings Account/Flexible Spending Account

Flexible Spending Accounts

Tuition Reimbursement

Family Support

Mental Health Support

Company Paid Life Insurance

Award/Recognition Programs

Company News

Simply Wall St
Apr 4th, 2026
Option Care Health expands credit facility to $850M, boosts buyback to $1B

Option Care Health has expanded its revolving credit facility by $450 million to $850 million and increased its share repurchase authorisation to $1 billion, whilst reaffirming its 2026 guidance. The moves strengthen liquidity and signal management confidence in cash generation. The expanded buyback and credit facility provide greater flexibility for growth investments and capital returns, though near-term focus remains on executing guidance and managing reimbursement pressures. The company's narrative projects $7 billion revenue and $302.2 million earnings by 2029, implying 7.5% annual revenue growth. Analyst fair value estimates range widely from $3.66 to $40.09 per share, with the upper estimate suggesting 46% upside from current prices.

MicroCare
Mar 9th, 2026
MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare.

MicroCare Medical welcomes Matt Lingenfelter as national sales manager, healthcare. March 09, 2026 MicroCare Medical is pleased to welcome Matt Lingenfelter as national sales manager, healthcare. With more than 20 years of experience in healthcare sales and leadership, Matt will help drive national growth and strengthen partnerships for the MicroCare Medical instrument care and infection prevention solutions. In this role, Matt will guide healthcare sales strategy across the U.S., focusing on expanding key accounts, building strong distributor relationships, and supporting the sales team. He will also work closely with marketing, operations, and product development to ensure MicroCare continues delivering solutions that meet the evolving needs of healthcare professionals. Before joining MicroCare, Matt held leadership roles with Option Care Health, Belimed, and Aesculap, where he developed deep expertise in surgical instrumentation, endoscopic technologies, and hospital system support. "Matt's experience and understanding of healthcare systems make him a fantastic addition to our team," said Ray Bellavance, vice president of global sales and marketing at MicroCare. "We're excited to have him help grow our healthcare business and strengthen partnerships across the country."

Yahoo Finance
Feb 27th, 2026
Option Care Health posts 13% revenue growth despite $25M–35M Stelara biosimilar headwind

Option Care Health reported a 13% revenue increase in Q4 2025, with acute therapies growing in the mid-teens and chronic therapies in the low double digits. The company served over 315,000 unique patients and improved operational efficiency, with 40% of claims now processed without human intervention. For 2026, the company issued revenue guidance of $5.8 billion to $6 billion, incorporating a 400 basis point headwind from Stelara biosimilar conversions and Inflation Reduction Act impacts. Adjusted EBITDA is projected at $480 million to $505 million, accounting for a $25 million to $35 million gross profit headwind from Stelara transitions. Operating cash flow is expected to exceed $340 million, representing over 30% growth. The company plans to launch at least two new pharmaceutical manufacturer programmes and expand its infusion clinic model to support higher-acuity therapies.

PREEMPT, Inc
Sep 30th, 2025
EEOC Sues Option Care Health, Inc. for Pregnancy Discrimination

EEOC sues Option Care Health, Inc. for pregnancy discrimination.

Option Care Health
Aug 7th, 2025
Quince Therapeutics Selects Option Care Health as Specialty Infusion Therapy Provider for Administration of Lead Asset eDSP

Quince Therapeutics selects Option Care Health as specialty infusion therapy provider for administration of lead asset eDSP.

INACTIVE